A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer
Clinical trial NCT00535522 · COMPLETED
Trial details
- NCT number
- NCT00535522
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-06-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.